Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients
Transcatheter aortic valve implantation (TAVI) has become an established treatment option for the treatment of aortic stenosis throughout the spectrum of surgical risk. Cerebral embolic protection devices (CEPDs) were developed to protect against embolization from the valve or vasculature during or post- surgery.
(2023). Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients. Cardiovascular Research Prove Journal, 7(2), -. doi: 10.21608/cvrepj.2023.351302
MLA
. "Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients", Cardiovascular Research Prove Journal, 7, 2, 2023, -. doi: 10.21608/cvrepj.2023.351302
HARVARD
(2023). 'Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients', Cardiovascular Research Prove Journal, 7(2), pp. -. doi: 10.21608/cvrepj.2023.351302
VANCOUVER
Cerebral Embolic Protection Devices and Transcatheter Aortic Valve Implantation. Could Neurological Complications Be Avoided? A MetaAnalysis Of 4091 Patients. Cardiovascular Research Prove Journal, 2023; 7(2): -. doi: 10.21608/cvrepj.2023.351302
)
View on SCiNiTO